tetano
Editor, Senior Moderator
Source: European Medicines Agency (EMA)
Date published: 16/12/2011 17:45
Summary
by: Yuet Wan
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Vepacel (A/H5N1 pre-pandemic influenza vaccine, whole virion, vero cell derived, inactivated) intended for the prophylaxis of H5N1 subtype of influenza A in either a pre-pandemic or pandemic situation in adults aged 18 years and older.
http://www.nelm.nhs.uk/en/NeLM-Area...Vepacel-AH5N1-pre-pandemic-influenza-vaccine/
Date published: 16/12/2011 17:45
Summary
by: Yuet Wan
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Vepacel (A/H5N1 pre-pandemic influenza vaccine, whole virion, vero cell derived, inactivated) intended for the prophylaxis of H5N1 subtype of influenza A in either a pre-pandemic or pandemic situation in adults aged 18 years and older.
http://www.nelm.nhs.uk/en/NeLM-Area...Vepacel-AH5N1-pre-pandemic-influenza-vaccine/